Global regulators agree on key principles on adapting vaccines to tackle virus variants

EMA

1 July 2022 - On 30 June, regulators from around the world discussed emerging evidence to support adaptation of COVID-19 vaccines as the SARS-COV-2 virus continues to evolve during a workshop co-chaired by the EMA and the US FDA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). 

The meeting focused on identifying key principles to support the adaption of COVID-19 vaccines to better match Omicron variants of concern, and on ensuring global regulatory alignment.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder